Anti-EGFR monoclonal antibodies plus chemotherapy in the first-line treatment of advanced NSCLC: a meta-analysis

Stock, GustavoAguiar, Pedro, Jr.Santoro, IlkaTadokoro, HakaruDe Mello, Ramon AndradeLopes, Gilberto2019-11-202019-11-202017-011556-08641556-1380http://hdl.handle.net/10400.1/13308engAnti-EGFR monoclonal antibodies plus chemotherapy in the first-line treatment of advanced NSCLC: a meta-analysisconference object